Search

everythinglearnresearchcommunity

for

Search:↓

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Nanoparticles can effectively treat diseases by modifying blood vessel growth.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Erlotinib can cause excessive eyelash growth.

An elderly woman with cancer improved after treatment for a rare skin condition with coiled hairs.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

Topical tofacitinib is effective and safe for treating alopecia areata.

No single treatment is clearly effective for central serous chorioretinopathy.

SVF may improve nanofat treatment for acne scars, but more research is needed.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

The new drug delivery system effectively targets lung cancer cells.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Vitamin C and E may help with certain skin and hair conditions, but more research is needed to confirm their effectiveness.

Standardizing PRP preparation and application could improve its effectiveness for chronic pain relief.

Hair loss in lupus patients indicates higher disease activity.

Nanocarrier technology in cosmetics improves ingredient delivery and effectiveness while reducing side effects.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

A new lab-grown lung model helps study adenoviruses and test antiviral drugs.

The treatment might help COVID-19 related hair loss, but more research is needed.

Idiopathic hirsutism is the most common cause of hirsutism in women, followed by PCOS.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Gut bacteria differences could help diagnose and treat alopecia areata.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.